Wessely, A.;                     Steeb, T.;                     Leiter, U.;                     Garbe, C.;                     Berking, C.;                     Heppt, M.V.    
        Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? Int. J. Mol. Sci. 2020, 21, 9300.
    https://doi.org/10.3390/ijms21239300
    AMA Style
    
                                Wessely A,                                 Steeb T,                                 Leiter U,                                 Garbe C,                                 Berking C,                                 Heppt MV.        
                Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? International Journal of Molecular Sciences. 2020; 21(23):9300.
        https://doi.org/10.3390/ijms21239300
    
    Chicago/Turabian Style
    
                                Wessely, Anja,                                 Theresa Steeb,                                 Ulrike Leiter,                                 Claus Garbe,                                 Carola Berking,                                 and Markus Vincent Heppt.        
                2020. "Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?" International Journal of Molecular Sciences 21, no. 23: 9300.
        https://doi.org/10.3390/ijms21239300
    
    APA Style
    
                                Wessely, A.,                                 Steeb, T.,                                 Leiter, U.,                                 Garbe, C.,                                 Berking, C.,                                 & Heppt, M. V.        
        
        (2020). Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? International Journal of Molecular Sciences, 21(23), 9300.
        https://doi.org/10.3390/ijms21239300